Smaller Companies

The Brexit vote, slowing global growth and unprecedented policy measures by central bankers mean there is significant uncertainty about what the future holds at a macroeconomic level - and there is good reason for investors to remain vigilant.

Increased focus on small and mid caps

Overuse of antibiotics around the globe has created a worrying increase in resistance to many commonly used drugs, writes Carl Harald Janson, lead manager on the International Biotechnology trust.

Co-manager Arnold will take lead role

Will join in September

Winners announced on 7 July

Positioning for Brexit

Technology stocks featured

Following a volatile few months, four fund managers discuss their outlook for small caps in the US and the UK, and where they believe the best sources of growth will be in 2016.

William Tamworth joined last year